INTRODUCTION
============

With recent overwhelming level 1 evidence \[[@b1-neuroint-2018-00997]-[@b7-neuroint-2018-00997]\] for the efficacy and safety of mechanical thrombectomy over best medical management for large vessel occlusion acute ischemic strokes, there has been a shift in research priorities towards optimizing time to recanalization, imaging protocols, risk stratification and selection criteria, and development and assessment of newer thrombectomy techniques. One such challenge to be addressed is understanding the effectiveness and role of mechanical thrombectomy in patients with more distal vessel occlusions, and whether results in proximal large vessel occlusions can be extrapolated to this population or not.

For occlusions of the second part of the middle cerebral artery (MCA, M2 segment) and more distally, the occluded lumen is often smaller with thinner walls, which may be more technically challenging to access with a catheter and for stent-retriever deployment. As such, there is theoretically an increased risk of complications, such as dissection and perforation, for endovascular interventions in this area. Furthermore, the efficacy profile of mechanical thrombectomy in M2 and more distal occlusions may also differ. The ischemic penumbra volume of distal occlusions tends to be smaller and can also lessen the benefit of endovascular thrombectomy and may be more amenable to intravenous thrombolysis therapy \[[@b8-neuroint-2018-00997],[@b9-neuroint-2018-00997]\]. However, there is also the risk that important eloquent areas can be affected despite limited vascular territory involvement. As such, endovascular therapy for M2 occlusions remains controversial.

Current American Heart Association and Stroke Association guidelines \[[@b10-neuroint-2018-00997]\] support the use of mechanical thrombectomy for distal occlusions in selected patients within 6 hours of symptom onset. This can involve stent-retrieval or new aspiration first approach or A Direct Aspiration First Pass Technique (ADAPT) approach with large bore aspiration catheters for thrombectomy \[[@b11-neuroint-2018-00997]-[@b14-neuroint-2018-00997]\]. The ADAPT technique has potential benefits of a high rate of complete revascularization, reduced groin puncture to revascularization time, a lesser technical difficulty compared to stent-retrievers, and increased cost effectiveness \[[@b11-neuroint-2018-00997]-[@b14-neuroint-2018-00997]\]. There has been a prior systematic review \[[@b15-neuroint-2018-00997]\] exploring the role of endovascular therapy in M2 occlusion strokes, reporting results from eight studies with overall successful reperfusion in 78% of cases and 90-day good mRS rates of 62%, with acceptable mortality and complication rates. However, there is limited literature directly comparing these two contemporary mechanical thrombectomy options in the context of endovascular interventions for M2 occlusion strokes. Therefore, we conducted a systematic review and meta-analysis to compare reperfusion rates and complications of stent-retrieval versus contact aspiration for treating M2 segment occlusions and determine factors which correlate with favorable clinical outcome.

MATERIALS AND METHODS
=====================

Literature search strategy
--------------------------

The present study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses and recommended guidelines for systematic reviews \[[@b16-neuroint-2018-00997]\]. Systematic searches of electronic databases were performed using Ovid Medline, PubMed, Cochrane Central Register of Controlled Trials (CCTR), Cochrane Database of Systematic Reviews (CDSR), ACP Journal Club, and Database of Abstracts of Review of Effectiveness (DARE) from their dates of inception to September 2017. The search strategy entailed combination of the terms "stroke", "middle cerebral artery", "MCA", "thrombectomy", "endovascular", "thrombectomy", "ADAPT", or "FAST". The reference lists of all retrieved articles were reviewed for further identification of potentially relevant studies and assessed using the inclusion and exclusion criteria.

Selection criteria
------------------

Eligible studies for the present systematic review and meta-analysis included cohorts of patients with distal MCA occlusion acute ischemic stroke that were treated with an endovascular approach including stent-retrieval technology or contact aspiration. All studies which reported outcome for M2 and distal MCA occlusions (regardless of specific anatomical or territorial definition) were included for consideration for analysis. However, the M2 segment was generally defined as vertical MCA branches originating at the genu to the apex of the circular sulcus. Included studies must have reported either thrombolysis in cerebral infarction (TICI) 2b--3 outcomes or modified Rankin scale (mRS) outcomes at follow-up \[[@b17-neuroint-2018-00997]\].

Studies which had fewer than 10 patients with acute M2 occlusions were excluded. Studies published before January 1, 2015 were excluded in order to capture modern thrombectomy results. When institutions published duplicate studies with accumulating numbers of patients or increased lengths of follow-up, only the most complete reports were included for quantitative assessment at each time interval. All publications were limited to those involving human subjects and in the English language. Abstracts, case reports, conference presentations, editorials, reviews, and expert opinions were excluded.

Data extraction
---------------

All data were extracted from article texts, tables, and figures by two reviewers (K.P. and J.M.) and discrepancies were discussed via consensus. If a study provided medians and interquartile ranges instead of means and standard deviations (SDs), we imputed the means and SDs as described by Hozo et al. \[[@b18-neuroint-2018-00997]\] Demographic data studied included year, study period, number of patients, age, gender, hypertension, hyperlipidemia, diabetes, atrial fibrillation, prior stroke/transient ischemic attack (TIA), current smoker, treatment window, National Institute of Health Stroke Scale (NIHSS) score at presentation, Alberta Stroke Program Early Computed Tomography Score (ASPECTS), and use of intravenous tissue plasminogen activator (IV-tPA).Treatment parameters included thrombectomy technique, successful reperfusion/recanalization of TICI 2b--3, onset to door time, onset to groin puncture time, time of groin puncture to recanalization. Outcome data included mRS 0--2 (good) and mRS 0--1 (excellent) at 90-day follow-up, mortality, total intracerebral hemorrhage (ICH), symptomatic ICH (sICH), asymptomatic ICH (aICH), and procedural complications including perforation, dissection, and distal embolization.

Statistical analysis
--------------------

A meta-analysis of proportions was conducted for the available main perioperative and postoperative variables, using logit transformation and combined using DerSimonian-Liard random effects models. Heterogeneity was evaluated using Cochran Q and I^2^ test. Heterogeneity was defined as none (I^2^=0%), low (I^2^=25%), moderate (I^2^=50%), or high (I^2^=75%) \[[@b19-neuroint-2018-00997]\]. A formal statistical comparison was performed between stent-retrieval versus contact aspiration techniques using mixed-effects meta-regression with a moderator variable for thrombectomy technique. Weighted meta-regression analysis was performed to determine whether baseline factors could be associated with outcome and hence be potential confounders. All analyses were performed using the metafor package for R version 3.01. P values \<0.05 were considered statistically significant.

RESULTS
=======

Search strategy
---------------

A total of 461 articles were identified through the electronic database searches and from other sources including reference lists ([Fig. 1](#f1-neuroint-2018-00997){ref-type="fig"}). After exclusion of duplicate or irrelevant references, 54 potentially relevant articles were retrieved. After detailed evaluation, 12 studies \[[@b8-neuroint-2018-00997],[@b9-neuroint-2018-00997],[@b20-neuroint-2018-00997]-[@b30-neuroint-2018-00997]\] were included for assessment ([Supplementary Table 1](#SD1-neuroint-2018-00997){ref-type="supplementary-material"}), including 835 cases of distal occlusions of the MCA (predominantly M2 occlusions). Results for contact aspiration were reported in 6 studies \[[@b9-neuroint-2018-00997],[@b20-neuroint-2018-00997],[@b21-neuroint-2018-00997],[@b24-neuroint-2018-00997],[@b25-neuroint-2018-00997],[@b30-neuroint-2018-00997]\] whilst stent-retrieval outcomes were reported in 10 studies \[[@b8-neuroint-2018-00997],[@b9-neuroint-2018-00997],[@b21-neuroint-2018-00997]-[@b24-neuroint-2018-00997],[@b26-neuroint-2018-00997]-[@b29-neuroint-2018-00997]\]. Out of the 835 included cases, there were 223 patients in the contact aspiration group and 612 patients in the stent-retrieval group. All studies were observational in nature except for the Contact Aspiration Versus Stent Retriever for Successful Revascularization (ASTER) randomized trial \[[@b21-neuroint-2018-00997]\]; however, M2 occlusions constituted only a subgroup of patients of this study. Definitions of M2 occlusions for each included study are summarized in [Supplementary Table 2](#SD2-neuroint-2018-00997){ref-type="supplementary-material"}.

Baseline characteristics
------------------------

Overall, patients were elderly with mean age of 69.9 years, which was not significantly different between stent-retriever vs contact aspiration cohorts. There were no differences in the proportions of females between stent-retriever and aspiration cohorts. Hypertension was more prevalent in stent-retriever patients (68.5% vs. 54.3%, P=0.047) as was hyperlipidemia (45.4% vs. 19.6%, P=0.015). There were no differences between the groups in terms of diabetes, atrial fibrillation, coronary artery disease, prior stroke/TIA, current smoking, or IV-tPA use. Pooled baseline NIHSS scores and ASPECTS imaging scores were also similar between stent-retriever and contact aspiration groups ([Table 1](#t1-neuroint-2018-00997){ref-type="table"}).

Treatment characteristics
-------------------------

Pooled time onset of symptoms to door arrival was significantly higher for the stent-retrieval group compared to contact aspiration (154 vs. 97.4 minutes, P=0.01), as was time to groin puncture (259.9 vs. 156.2 minutes, P=0.021). There were no significant differences in time from groin puncture to recanalization (35.6 vs. 40.8 minutes, P=0.273).

Clinical outcomes
-----------------

The primary outcome, the proportion of TICI 2b--3 recanalization, was similar for stent-retrievers and contact aspiration (80.5% vs. 86.8%, P=0.168) ([Fig. 2](#f2-neuroint-2018-00997){ref-type="fig"}). This was associated with a moderate level of heterogeneity (I^2^=36.98% overall). TICI 3 was also comparable (53.5% vs. 57.1%, P=0.70). The secondary outcome, mRS 0--2 at 90-day follow-up, was similar for stent-retrievers and contact aspiration (59.9% vs. 74.5%, P=0.120) ([Table 2](#t2-neuroint-2018-00997){ref-type="table"}, [Fig. 3](#f3-neuroint-2018-00997){ref-type="fig"}). This was associated with a significant level of heterogeneity (I^2^=51.66% overall). Excellent mRS at 90-days was also significantly lower for stent-retrievers (39.9% vs. 65.6%, P=0.003). No differences were noted in terms of 90-day mortality (14.7% vs. 4.3%, P=0.177) ([Fig. 4](#f4-neuroint-2018-00997){ref-type="fig"}) with a fair level heterogeneity (I^2^=23.58%), any ICH (11.7% vs. 9.4%, P=0.53), sICH (5.7% vs. 2.6%, P=0.183) with low heterogeneity (I^2^=0%), or aICH (6.6% vs. 4.1%, P=0.378). There were no significant differences in procedural complications between stent-retrieval and aspiration first techniques in terms of distal embolization (5.9% vs. 4.6%, P=0.598) or dissection/perforation (3.8% vs. 1.9%, P=0.344).

Correlation analysis
--------------------

In order to investigate potential contributing or confounding factors driving differences in clinical outcomes between stent-retrieval versus aspiration techniques, we performed correlation analysis using baseline variables that were significantly different. Significant negative correlation was found between onset to groin puncture time and the proportion of patients with a good mRS (r=-0.71, P=0.048). However, no significant correlations were found for onset to door time, hypertension, or hyperlipidemia with a good mRS clinical outcome ([Fig. 5](#f5-neuroint-2018-00997){ref-type="fig"}).

DISCUSSION
==========

In this study, the efficacy of both stent-retrieval and contact aspiration techniques were demonstrated in distal M2 acute ischemic strokes. In particular, favorable recanalization rates and thrombectomy procedure times were equivalent between the two cohorts. The proportion of patients with good mRS outcome was similar between the two thrombectomy techniques; however, excellent clinical outcome at 90-days was significantly lower for stent-retrieval thrombectomy, although this was on a background of higher baseline comorbidities of hypertension and hyperlipidemia as well as increased symptom onset to groin puncture times. Our analysis also demonstrated that onset to groin puncture time was the best correlate of clinical outcome at follow-up and justifies the differences observed in clinical outcomes between the aspiration and stent-retrieval groups in our meta-analysis. As such, our findings suggest that endovascular treatment of MCA M2 occlusions by contact aspiration is at least similar to that of stent-retrieval, and that reducing onset to groin puncture time is associated with improved 90-day clinical outcome. Overall, our findings share similarities with level 1 evidence for endovascular therapy for large anterior vessel occlusion strokes, supporting the evolving role of endovascular thrombectomy for distal occlusions.

To date, endovascular therapy in distal MCA strokes remains controversial for several reasons. Firstly, distal MCA strokes tend to have more favorable presentations and outcomes relative to large vessel occlusions, due to smaller infarct and penumbra volumes. In such patients, alteplase tends to have reasonable effectiveness and thus not all patients are candidates for intra-arterial intervention \[[@b8-neuroint-2018-00997],[@b9-neuroint-2018-00997]\]. However, recanalization with alteplase may be inadequate for some patients, and endovascular intervention could be of benefit. In a natural history study of acute ischemic strokes, Hernández-Pérez et al. \[[@b31-neuroint-2018-00997]\] demonstrated poor clinical outcomes (mRS \>2 at 3 months) and 3% deaths in distal MCA occlusion cases without reperfusion therapy. Lima et al. \[[@b32-neuroint-2018-00997]\] observed poor mRS \>2 in 46% of 48 cases of acute M2 occlusions, resulting in 21% mortality when intervention was not performed. As such, there is certainly a subset of distal occlusion acute ischemic stroke patients who could benefit from a more aggressive endovascular therapy as first line treatment. With regards to current randomized evidence thus far, distal MCA occlusions such as M2 were significantly under-represented in the major randomized trials proving the benefit of endovascular therapy for large vessel occlusion strokes. Of the randomized studies included in the HERMES collaborative meta-analysis \[[@b6-neuroint-2018-00997]\], only two trials \[[@b1-neuroint-2018-00997],[@b2-neuroint-2018-00997]\] enrolled a minor fraction of cases with distal occlusions. Of five trials assessed, 7.3% of patients had isolated M2 segment occlusions, and 51 of these cases received endovascular treatment. Their analysis was unable to confirm any harm of endovascular therapy in distal MCA occlusions \[[@b6-neuroint-2018-00997]\], suggesting that the benefits of endovascular therapy in acute ischemic strokes extends to the M2 occlusion group of stroke patients. However, the nature of the M2 occlusions which could have been "large" M2 and not "distal M2" is unclear, and may have been considered M1 by local means and M2 by core lab, given that not all trials were core-lab adjudicated.

With regards to the choice of thrombectomy technique, there are concerns regarding their complication profiles. The smaller, thinned-walled vasculature of distal MCA occlusions are susceptible to perforation or dissection complications of thrombectomy, particularly for stent-retrievers. Contact aspiration has been an increasingly popular option for mechanical thrombectomy, particularly with recent advancements in catheter technology resulting in increased suction force, flexibility, and less traumatic tips \[[@b11-neuroint-2018-00997],[@b20-neuroint-2018-00997]\]. However, there are currently no randomized trials comparing aspiration versus stent-retriever techniques for distal MCA M2 occlusions. The recently published ASTER (The Contact Aspiration vs. Stent Retriever for Successful Revascularization) study compared 192 patients who underwent first-line contact aspiration versus 189 cases of first-line stent retriever cases in patients with acute ischemic strokes. The proportion of cases with successful revascularization, change in NIHSS score, and adverse event rates were comparable between the two arms of this trial; however, it was noted that M2 occlusions comprised only 20.7% of patients in this trial, and hence their conclusions cannot be directly extrapolated to all distal MCA strokes. Their results were similar to those of the present meta-analysis, in that there was a similar rate of distal embolization, perforation, and dissection complications between the two techniques. In terms of technical success rate in our meta-analysis, both aspiration first approaches and stent-retriever techniques achieved equivalent reperfusion rates, indicating similar technical efficacy of either approach.

In agreement with prior studies, such as the ASTER randomized trial, that did not demonstrate any significant difference in clinical outcomes between aspiration versus stent-retriever approaches, our meta-analysis demonstrated similar TICI 2b--3 recanalization rates for both thrombectomy techniques. While mRS 0--1 was significantly more favorable for aspiration, this difference was not necessarily due to differences in the efficacy of treatment, but could also be potentially attributed to confounders, such as differences in baseline characteristics or time delays to groin puncture. Correlation analysis demonstrated that onset to groin puncture time was significantly negatively correlated with clinical outcome. As such, the differences in 90-day favorable mRS in aspiration versus stent-retriever cohorts may be explained by a larger portion of aspiration first cases having a shorter duration of onset to puncture, thus resulting in improved clinical outcomes. This is supported by the multivariate adjusted analysis of Kim et al. \[[@b9-neuroint-2018-00997]\], which demonstrated that time to recanalization was an independent predictor of favorable clinical outcome for M2 segment occlusions. However, in contrast to Kim et al. \[[@b9-neuroint-2018-00997]\], the present meta-analysis did not find age to be a significant confounding factor. The relative benefits of contact aspiration versus stent-retrieval on clinical outcomes at follow-up require further investigation and confirmation by prospective multi-center randomized controlled trials.

The present study is limited by several constraints. First, there was no control medical therapy group or natural history cohort to compare the endovascular therapy outcomes to. The HERMES study subgroup analysis demonstrated no significant difference in outcome between medically managed and endovascular intervened cases in terms of good mRS outcome, with an odds ratio of 1.28 (0.51--3.21), however raw data for this subgroup was not provided and thus could not be included for comparative analysis in the present meta-analysis. In terms of endpoints, several key parameters such as time of onset to imaging or time of imaging to groin puncture were not reported by the majority of included studies and their influence on clinical outcome could not be assessed in the present meta-analysis. A variety of stent-retrieval devices and aspiration catheters were used, which further adds heterogeneity to the pooled analysis. Varying anatomical complexity, such as branching and tortuosity, could not be accounted for in this meta-analysis and has the potential to contribute to the reduced effectiveness of mechanical thrombectomy. There was also a lack of homogeneity in terms of definition of M2 used in the included studies (Supplementary [Table 2](#t2-neuroint-2018-00997){ref-type="table"}), and there is prior evidence that M2 segment definition and occlusion location can lead to differences in reported revascularization rates and good outcomes \[[@b29-neuroint-2018-00997]\]. The use of general anesthesia versus conscious sedation has also been shown to have a significant influence on clinical outcome in large vessel occlusions; however, we were unable to test this in our meta-analysis. Mokin et al. \[[@b24-neuroint-2018-00997]\] reported however that choice of sedation, whether conscious or general, had no effect on the outcomes of thrombectomy for M2 occlusions. We were also unable to perform a meta-analysis of adjusted effect sizes for various confounders, as in most cases this was not reported in the included studies. Other limitations which undermine the validity of the results include the retrospective observational nature of the majority of included studies, which lends itself to selection bias. Furthermore, this study is not randomized, and the difference in baseline characteristics, such as time of symptom onset to groin puncture, complicates comprehensive analysis of this data. Finally, there was a moderate to strong heterogeneity in many of the analyses we performed, which is probably due to the many differences in definitions, methods, and study populations included in this meta-analysis.

CONCLUSION
==========

In conclusion, both endovascular techniques achieved recanalization rates greater than 80% and 90-day outcomes of minimal disability with similar complication rates. The current literature is skewed by aspiration cases being performed sooner after onset of stroke compared to stent-retriever cases, and this limits interpretation and generalizability of pooled outcomes. The current findings need to be assessed in the setting of a prospective, multi-center randomized trial.

SUPPLEMENTARY MATERIALS
=======================

Supplementary materials related to this article can be found online at <https://doi.org/10.5469/neuroint.2018.00997>.

![PRISMA flow chart of search strategy for the present systematic review and meta-analysis. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; MCA, middle cerebral artery; mRS, modified Rankin scale; TICI, thrombolysis in cerebral infarction.](neuroint-2018-00997f1){#f1-neuroint-2018-00997}
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![Forest plot compares pooled outcomes of stent-retriever versus contact aspiration for 90-day mRS 0--2 (P-value for difference 0.041). CI, confidence interval; Ev, events; Trt, treatment; ADAPT, A Direct Aspiration First Pass Technique; mRS, modified Rankin scale.](neuroint-2018-00997f3){#f3-neuroint-2018-00997}

![Forest plot compares pooled outcomes of stent-retriever versus contact aspiration for 90-day mortality (P-value for difference 0.212). CI, confidence interval; Ev, events; Trt, treatment; ADAPT, A Direct Aspiration First Pass Technique.](neuroint-2018-00997f4){#f4-neuroint-2018-00997}

![Correlation analysis for good clinical outcome mRS 0--2. Open circles represent contact aspiration, closed circles represent stent-retriever thrombectomy. mRS, modified Rankin scale.](neuroint-2018-00997f5){#f5-neuroint-2018-00997}

###### 

Baseline and procedural characteristics

  Variable                                             Overall               Stent-retriever       Aspiration first    P-value for difference
  ---------------------------------------------------- --------------------- --------------------- ------------------- ------------------------
  Age (years)                                          69.9 (67.5-72.3)      69.8 (66.1-73.5)      70.7 (69.4-72.0)    0.931
  Females (%)                                          45.7 (40.8-50.6)      46.2 (40.4-52.1)      43.9 (33.8-54.4)    0.518
  Hypertension (%)                                     65.3 (57.0-72.8)      68.5 (60.3-75.7)      54.3 (41.3-66.8)    0.047
  Hyperlipidaemia (%)                                  37.0 (24.9---51.0)    45.4 (31.4-60.2)      19.6 (11.2-32.1)    0.015
  Diabetes (%)                                         21.5 (18.0---25.5)    22.3 (18.0-27.2)      16.1 (8.6-28.3)     0.314
  Atrial fibrillation (%)                              41.0 (32.0-50.7)      40.8 (33.6-48.5)      29.0 (2.9-84.9)     0.473
  Coronary artery disease (%)                          11.4 (5.5-22.0)       13.2 (5.6-28.0)       8.0 (2.0-26.9)      0.527
  Prior stroke/TIA (%)                                 13.1 (8.2-20.3)       12.1 (6.2-22.4)       14.1 (7.2-25.8)     0.742
  Current smoker                                       14.4 (6.7-28.5)       11.2 (3.6-29.7)       23.1 (13.9-35.9)    0.224
  Alteplase use                                        58.2 (47.5-68.1)      57.5 (47.0-67.3)      66.1 (33.4-88.3)    0.690
  NIHSS baseline                                       13.6 (12.4-14.9)      13.6 (11.9-15.3)      13.8 (11.9-15.7)    0.857
  ASPECTS baseline                                     8.7 (8.3-9.1)         8.8 (8.3-9.3)         8.5 (7.5-9.5)       0.682
  Onset to door time (minutes)                         129.1 (70.6-187.6)    154.0 (146.0-162.0)   97.4 (22.0-172.8)   0.010
  Onset to groin puncture time (minutes)               220.9 (110.3-331.5)   259.9 (229.2-290.6)   156.2 (5.3-307.1)   0.021
  Time of groin puncture to recanalization (minutes)   37.5 (32.3-42.7)      35.6 (29.6-41.7)      40.8 (26.0-55.6)    0.273

Values are presented as either weighted mean (95% confidence interval).

TIA, transient ischemic attack; NIHSS, National Institute of Health Stroke Scale; ASPECTS, Alberta Stroke Program Early Computed Tomography Score.

###### 

Meta-analysis of procedural and 90-day outcomes

  Variable                        Overall            Stent-retriever    Aspiration first   P-value for difference
  ------------------------------- ------------------ ------------------ ------------------ ------------------------
  TICI 2b-3 (%)                   82.8 (78.5-86.4)   80.5 (76.1-84.3)   86.8 (77.6-92.6)   0.168
  TICI 3 (%)                      55.8 (47.0-64.3)   53.5 (42.9-63.9)   57.1 (43.3-69.9)   0.700
  90-day mRS 0-2 (%)              62.0 (55.8-67.8)   59.9 (55.8-63.8)   74.5 (56.4-86.8)   0.120
  90-day mRS 0-1 (%)              44.2 (33.7-55.2)   39.9 (31.5-49.0)   65.6 (47.9-79.8)   0.003
  90-day mortality (%)            12.4 (8.9-17.0)    14.7 (11.0-19.4)   4.3 (1.2-14.5)     0.212
  All ICH (%)                     11.2 (8.5-14.5)    11.7 (8.6-15.6)    9.4 (5.0-16.8)     0.530
  sICH (%)                        5.3 (3.7-7.5)      5.7 (3.9-8.3)      2.6 (0.8-7.7)      0.183
  aICH (%)                        6.0 (4.2-8.3)      6.6 (4.1-10.5)     4.1 (1.6-9.9)      0.378
  Distal embolization (%)         5.7 (1.8-17.2)     5.9 (0.6-39.4)     4.6 (0.9-20.0)     0.598
  Dissection or perforation (%)   3.3 (1.7-6.5)      3.8 (1.6-8.7)      1.9 (0.5-7.2)      0.344

TICl, thrombolysis in cerebral infarction scale; mRS, modified Rankin scale; ICH, intracerebral hemorrhage; sICH, symptomatic intracerebral hemorrhage; aICH, asymptomatic intracerebral hemorrhage.
